Discontinued drugs in 2005: anti-infectives

Bibliography

• TENOVER FC: Mechanisms of antimicrobial resistance in bacteria. Am. J. Infect. Control. (2006) 34(5 Suppl. 1):S3-S10 (Discussion S64-573).
   PubMed Web of Science ®Google Scholar
• LODE H: Management of serious nosocomial bacterial infections: do current therapeutic options meet the need? Clin. Microbiol. Infect. (2005) 11(10):778-787.
   PubMed Web of Science ®Google Scholar
• DONSKEY CJ: Antibiotic regimens and intestinal colonization with antibiotic-resistant Gram-negative bacilli. Clin. Infect. Dis. (2006) 43(Suppl. 2):S62-S69.
   PubMedGoogle Scholar
• BONOMO RA, SZABO D: Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin. Infect. Dis. (2006) 43(Suppl. 2):S49-S56.
   PubMed Web of Science ®Google Scholar
• RICE LB: Antimicrobial resistance in Gram-positive bacteria. Am. J. Infect. Control. (2006) 34(5 Suppl. 1):S11-S19 (Discussion S64-S73).
   PubMed Web of Science ®Google Scholar
• CHAMBERS HF: Community-associated MRSA-resistance and virulence converge. N. Engl. J. Med. (2005) 352(14):1485-1487.
   PubMed Web of Science ®Google Scholar
• KAUFFMAN CA: Fungal infections. Proc. Am. Thorac. Soc. (2006) 3(1):35-40.
   PubMedGoogle Scholar
• NUCCI M, MARR KA: Emerging fungal diseases. Clin. Infect. Dis. (2005) 41(4):521-526.
   PubMed Web of Science ®Google Scholar
• PFALLER MA, DIEKEMA DJ: Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J. Clin. Microbiol. (2004) 42(10):4419-4431.
   PubMed Web of Science ®Google Scholar
• CHARLES M, PAPE JW: Tuberculosis and HIV: implications in the developing world. Curr. HIV/AIDS Rep. (2006) 3(3):139-144.
   PubMedGoogle Scholar
• JOHNSON R, STREICHER EM, LOUW GE, WARREN RM, VAN HELDEN PD, VICTOR TC: Drug resistance in Mycobacterium tuberculosis. Curr. Issues Mol. Biol. (2006) 8(2):97-111.
   PubMed Web of Science ®Google Scholar
• POL S, MALLET VO: Improving anti-hepatitis C virus therapy. Expert Opin. Biol. Ther. (2006) 6(9):923-933.
   PubMed Web of Science ®Google Scholar
• ANDERSSON K, CHUNG RT: Hepatitis C virus in the HIV-infected patient. Clin. Liver Dis. (2006) 10(2):303-320 (viii).
   PubMedGoogle Scholar
• WEIS N, LINDHARDT BO, KRONBORG G et al.: Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. Clin. Infect. Dis. (2006) 42(10):1481-1487.
   PubMed Web of Science ®Google Scholar
• CHUNG RT: Hepatitis C and B viruses: the new opportunists in HIV infection. Top. HIV Med. (2006) 14(2):78-83.
   PubMedGoogle Scholar
• DAILY JP: Antimalarial drug therapy: the role of parasite biology and drug resistance. J. Clin. Pharmacol. (2006) 46(12):1487-1497.
   PubMed Web of Science ®Google Scholar
• BLOLAND PB, BARAT LM: Drug resistance among malaria and other parasites. Infect. Dis. Clin. North Am. (1997) 11(4):969-987.
   PubMed Web of Science ®Google Scholar
• TROUILLER P, TORREELE E, OLLIARO P et al.: Drugs for neglected diseases: a failure of the market and a public health failure? Trop. Med. Int. Health (2001) 6(11):945-951.
   PubMed Web of Science ®Google Scholar
• TALBOT GH, BRADLEY J, EDWARDS JE Jr, GILBERT D, SCHELD M, BARTLETT JG: Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. (2006) 42(5):657-668.
   PubMed Web of Science ®Google Scholar
• NORRBY SR, NORD CE, FINCH R; EUROPEAN SOCIETY OF CLINICAL MICROBIOLOGY AND INFECTIOUS DISEASES: Lack of development of new antimicrobial drugs: a potential serious threat to public health. Lancet Infect. Dis. (2005) 5(2):115-119.
   PubMed Web of Science ®Google Scholar
• POWERS JH: Development of drugs for antimicrobial-resistant pathogens. Curr. Opin. Infect. Dis. (2003) 16(6):547-551.
   PubMed Web of Science ®Google Scholar
• WATERS L, NELSON M: New therapeutic options for hepatitis C. Curr. Opin. Infect. Dis. (2006) 19(6):615-622.
   PubMed Web of Science ®Google Scholar
• REED C, DAAR ES: Novel antiretroviral agents in HIV therapy. Curr. Infect. Dis. Rep. (2006) 8(6):489-496.
   PubMedGoogle Scholar
• HARTFORD CG, PETCHEL KS, MICKAIL H et al.: Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines. Drug Saf. (2006) 29(8):657-673.
   PubMed Web of Science ®Google Scholar
• SENNEVILLE E, LEGOUT L, VALETTE M et al.: Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study. J. Antimicrob. Chemother. (2004) 54(4):798-802.
   PubMed Web of Science ®Google Scholar
• KASBEKAR N, ACHARYA PS: Telithromycin: the first ketolide for the treatment of respiratory infections. Am. J. Health Syst. Pharm. (2005) 62(9):905-916.
   PubMed Web of Science ®Google Scholar
• GUETTOUCHE T, HNATYSZYN HJ: Chronic hepatitis B and viral genotype: the clinical significance of determining HBV genotypes. Antivir. Ther. (2005) 10(5):593-604.
   PubMed Web of Science ®Google Scholar
• KAPOOR A, JONES M, SHAFER RW, RHEE SY, KAZANJIAN P, DELWART EL: Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay. J. Virol. (2004) 78(13):7112-7123.
   PubMed Web of Science ®Google Scholar
• SNOUNOU G, BECK HP: The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Parasitol. Today (1998) 14(11):462-467.
   PubMedGoogle Scholar
• DANEMAN N, McGEER A, GREEN K, LOW DE: Toronto Invasive Bacterial Diseases Network. Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin. Infect. Dis. (2006) 43(4):432-438.
   PubMed Web of Science ®Google Scholar
• 7th International Conference on AIDS, Florence, Italy (1991):WA1016-8 (Abstract).
   Google Scholar
• 7th International Conference on AIDS, Florence, Italy (1991):WA1020 (Abstract).
   Google Scholar
• 7th International Conference on AIDS, Florence, Italy (1991):WA1034 (Abstract).
   Google Scholar
• 7th International Conference on AIDS, Florence, Italy (1991):WA1041 (Abstract).
   Google Scholar
• 7th International Conference on AIDS, Florence, Italy (1991):WB2114 (Abstract).
   Google Scholar
• 7th International Conference on AIDS, Florence, Italy (1991):ThA21 (Abstract).
   Google Scholar
• 8th International Conference on AIDS, Amsterdam (1992):WeB1012 (Abstract).
   Google Scholar
• 8th International Conference on AIDS, Amsterdam (1992):PoB3025 (Abstract).
   Google Scholar
• 10th Conference on Retroviruses and Opportunistic Infections, Boston, USA (2003).
   Google Scholar
• 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, USA (2004):H-211 (Abstract).
   Google Scholar
• 15th International AIDS Conference, Bangkok, China (2004):WeOrA1231 (Abstract).
   Google Scholar
• 12th Conference on Retroviruses and Opportunistic Infections, Boston, USA (2005):543 (Abstract).
   Google Scholar
• 12th Conference on Retroviruses and Opportunistic Infections, Boston, USA (2005):664 (Abstract).
   Google Scholar
• 12th Conference on Retroviruses and Opportunistic Infectious Diseases, Boston, USA (2005):664 (Abstract).
   Google Scholar
• 53rd Meeting of the American Association for the Study of Liver Diseases, Boston, USA (2002):464 (Abstract).
   Google Scholar
• 53rd Meeting of the American Association for the Study of Liver Diseases, Boston, USA (2002):800 (Abstract).
   Google Scholar
• 53rd Meeting of the American Association for the Study of Liver Diseases, Boston, USA (2003).
   Google Scholar
• TAN S-L, ARNIM P, Y SHI, NAHUM S: Hepatitis C therapeutics: current status and emerging strategies. Nat. Rev. Drug Discov. (2002) 1:867.
   PubMed Web of Science ®Google Scholar
• 18th International Symposium on Medicinal Chemistry, Copenhagen, Denmark (2004):L29 (Abstract).
   Google Scholar
• 2nd International Conference on Viral Hepatitis, Hawaii, USA (1998):P35(Abstract).
   Google Scholar
• American Association for the Study of Liver Diseases, Boston, USA (2003):312(Abstract).
   Google Scholar